INFLAMMATORY BIOMARKERS AND HPV-ASSOCIATED ORAL PRE-CANCER
INFLAMMATORY BIOMARKERS AND HPV-ASSOCIATED ORAL PRE-CANCER
批准号:
7266178
负责人:
Anh D Le
金额:
$8.15万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-07-05 至 2009-06-30
关键词:
AddressAffectAfrican AmericanAlcohol consumptionAmerican Cancer SocietyAnti-Inflammatory AgentsAnti-inflammatoryBiological MarkersBlood specimenCaliforniaCancer BurdenCancerousCellsChemopreventionCommunitiesCountyCustomDetectionDevelopmentDiagnosisDiagnosticEpidemiologic StudiesEthnic groupFailureFutureGeneticGenotypeGrowthHPV-High RiskHabitsHead and Neck CancerHead and neck structureHispanicsHistologicHospitalsHumanHuman PapillomavirusHuman papilloma virus infectionHuman papillomavirus 16Immunologic SurveillanceIncidenceIndividualInfectionInflammationInflammatoryIntegration Host FactorsInterventionInvasiveLeadLesionLifeLife StyleLos AngelesMalignant NeoplasmsMalignant neoplasm of cervix uteriMedical centerMinorityMolecular ProfilingMonitorMorbidity - disease rateOralOral DiagnosisOral LeukoplakiaOral cavityPapillomavirusPatientsPilot ProjectsPopulationPremalignantProteinsRateRiskRisk FactorsSalivaScreening for Oral CancerScreening procedureSerumSexually Transmitted DiseasesSpecimenSpottingsSquamous intraepithelial lesionStudy modelsSubgroupTestingTherapeutic InterventionTimeTobaccoTobacco smokingUniversitiesVirusVirus Diseasesbasecancer therapycase controlcytokinedesignimprovedmalemalignant mouth neoplasmmortalityprognosticresponsetooltumortumor initiationtumor progression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Despite advances in cancer therapy, discrepancy in the morbidity and mortality rates of oral cancer among minority patients has remained unchanged. Tobacco and alcohol consumption have been associated as risk factors in oral cancer, however, these habits fail to explain all cases of head and neck malignancy. Human papilloma virus (HPV), a well established risk factor in invasive cervical cancer, has also been identified in several oral pre-cancerous lesions. A pilot study of head and neck cancer and HPV screening using the Roche Linear Array HPV genotyping test conducted at Los Angeles County-University of Southern California (LAC- USC) medical center during 2005-2006 has demonstrated that 45% of tumor specimens were HPV positive at any time with 100% of positive tumors harboring HPV 16. In the past decades, HPV infection has become one of the most prevalent sexual transmitted infections in the underserved communities, Hispanics and African Americans, as compared to other ethnic groups. The overall objective of this study is to determine whether HPV is related to oral pre-malignant cancer and oral cancer in minority patients living in Los Angeles County and to identify inflammation-associated biomarkers as diagnostic and prognostic tools for oral cancer progression. The following specific aims will be addressed in this study: 1) To determine the association between human papilloma virus infection and oral leukoplakia among a minority population, African Americans and Hispanics, living in Los Angeles County; and 2) To evaluate pro-inflammatory and anti-inflammatory cytokines associated with HPV infected patients and oral leukoplakia as biomarkers for oral cancer progression. The specific objective is to identify potential inflammatory biomarkers in HPV-associated oral pre-cancer which may be used to identify high-risk subgroups among African American and Hispanic populations and to tailor appropriate intervention strategies to reduce the incidence of oral cancer among these populations. The relationship between lifestyle factors, such as tobacco smoking, alcohol consumption and HPV infection, and genetic host factors will be studied using a hospital-based case-control design. The findings from this pilot study will lead to a future R01 application with potential to improve the quality of cancer epidemiologic research and reduce the oral cancer burden in minority populations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeted inhibition of eIF5Ahpu suppresses tumor growth and M2-like TAM polarization in oral cancer
-
批准号:10573290
-
项目类别:
-
资助金额:$45.38万
-
财政年份:2022
-
负责人:Anh D Le
-
依托单位:
Targeted inhibition of eIF5Ahpu suppresses tumor growth and M2-like TAM polarization in oral cancer
-
批准号:10441837
-
项目类别:
-
资助金额:$46.93万
-
财政年份:2022
-
负责人:Anh D Le
-
依托单位:
Therapeutic Potential of Gingival mesenchymal Stem Cell-derived Extracellular Vesicles Enriched with MFG-E8 in Peripheral Nerve Regeneration
-
批准号:10180941
-
项目类别:
-
资助金额:$24.38万
-
财政年份:2020
-
负责人:Anh D Le
-
依托单位:
Therapeutic Potential of Gingival mesenchymal Stem Cell-derived Extracellular Vesicles Enriched with MFG-E8 in Peripheral Nerve Regeneration
-
批准号:10042927
-
项目类别:
-
资助金额:$20.25万
-
财政年份:2020
-
负责人:Anh D Le
-
依托单位:
GINGIVA DERIVED MSCS: ROLE IN IMMUNOMODULATION AND TISSUE REGENERATION
-
批准号:7728606
-
项目类别:
-
资助金额:$59.47万
-
财政年份:2009
-
负责人:Anh D Le
-
依托单位:
GINGIVA DERIVED MSCS: ROLE IN IMMUNOMODULATION AND TISSUE REGENERATION
-
批准号:8271275
-
项目类别:
-
资助金额:$1.76万
-
财政年份:2009
-
负责人:Anh D Le
-
依托单位:
GINGIVA DERIVED MSCS: ROLE IN IMMUNOMODULATION AND TISSUE REGENERATION
-
批准号:7851425
-
项目类别:
-
资助金额:$59.75万
-
财政年份:2009
-
负责人:Anh D Le
-
依托单位:
GINGIVA DERIVED MSCS: ROLE IN IMMUNOMODULATION AND TISSUE REGENERATION
-
批准号:8070529
-
项目类别:
-
资助金额:$57.43万
-
财政年份:2009
-
负责人:Anh D Le
-
依托单位:
GINGIVA DERIVED MSCS: ROLE IN IMMUNOMODULATION AND TISSUE REGENERATION
-
批准号:8466720
-
项目类别:
-
资助金额:$50.67万
-
财政年份:2009
-
负责人:Anh D Le
-
依托单位:
GINGIVA DERIVED MSCS: ROLE IN IMMUNOMODULATION AND TISSUE REGENERATION
-
批准号:8600475
-
项目类别:
-
资助金额:$54.45万
-
财政年份:2009
-
负责人:Anh D Le
-
依托单位:
BOWMAN-BIRK INHIBITOR CONCENTRATE & ORAL LEUKOPLAKIA: PHASE IIB TRIAL (UNIVER
-
批准号:7716696
-
项目类别:
-
资助金额:$0.48万
-
财政年份:2008
-
负责人:Anh D Le
-
依托单位:
BOWMAN-BIRK INHIBITOR CONCENTRATE & ORAL LEUKOPLAKIA: PHASE IIB TRIAL (UNIVER
-
批准号:7982106
-
项目类别:
-
资助金额:$1.16万
-
财政年份:2008
-
负责人:Anh D Le
-
依托单位:
INFLAMMATORY BIOMARKERS AND HPV-ASSOCIATED ORAL PRE-CANCER
-
批准号:7463620
-
项目类别:
-
资助金额:$8.15万
-
财政年份:2007
-
负责人:Anh D Le
-
依托单位:
BOWMAN-BIRK INHIBITOR CONCENTRATE & ORAL LEUKOPLAKIA: PHASE IIB TRIAL (UNIVER
-
批准号:7603920
-
项目类别:
-
资助金额:$0.39万
-
财政年份:2006
-
负责人:Anh D Le
-
依托单位:
HYPOXIA REGULATION OF VEGF/VEGF RECEPTORS IN KELOIDS
-
批准号:6534519
-
项目类别:
-
资助金额:$28.93万
-
财政年份:2000
-
负责人:Anh D Le
-
依托单位:
HYPOXIA REGULATION OF VEGF/VEGF RECEPTORS IN KELOIDS
-
批准号:6231260
-
项目类别:
-
资助金额:$30.26万
-
财政年份:2000
-
负责人:Anh D Le
-
依托单位:
HYPOXIA REGULATION OF VEGF/VEGF RECEPTORS IN KELOIDS
-
批准号:6976742
-
项目类别:
-
资助金额:$31.29万
-
财政年份:2000
-
负责人:Anh D Le
-
依托单位:
HYPOXIA REGULATION OF VEGF/VEGF RECEPTORS IN KELOIDS
-
批准号:6659090
-
项目类别:
-
资助金额:$26.11万
-
财政年份:2000
-
负责人:Anh D Le
-
依托单位:
HYPOXIA REGULATION OF VEGF/VEGF RECEPTORS IN KELOIDS
-
批准号:6375374
-
项目类别:
-
资助金额:$31.12万
-
财政年份:2000
-
负责人:Anh D Le
-
依托单位:
HYPOXIA REGULATION OF VEGF/VEGF RECEPTORS IN KELOIDS
-
批准号:6796666
-
项目类别:
-
资助金额:$1.38万
-
财政年份:2000
-
负责人:Anh D Le
-
依托单位:
海外基金